Archive for the ‘japan retractions’ Category
A group of researchers in Tokyo has lost their 2013 article in the Journal of Crystal Growth over commercial interests — which don’t appear to be their own.
The article, “Interactions between planar defects in bulk 3C-SiC,” came from a team consisting of a researcher at Keio University and scientists at two companies, HOYA Corporation, an optics firm, and SICOXS Corporation, which makes semiconductor wafers.
Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship
The comments suggested that the figures in the paper had problems. Some bands seemed to be duplicated, and one of the images looked very much like that of another paper.
A group of pharmacologists in Japan has retracted their 2012 article in the International Journal of Pharmaceutics for plagiarism. But not, they note, for any other reason.
The article, “Suppression of efflux transporters in the intestines of endotoxin-treated rats,” came from researchers in the Department of Drug Absorption and Pharmacokinetics in the School of Pharmacy at Tokyo University of Pharmacy and Life Sciences. It has been cited once, according to Thomson Scientific’s Web of Knowledge.
Waseda University checking dissertations for plagiarism in wake of STAP stem cell misconduct finding
Waseda University in Japan says it will be vetting every doctoral dissertation it awards its graduate-level students in Advanced Science & Engineering* for signs of plagiarism, according to a report in the Japan News, a site of the Yomiuri Shimbun. The paper reports that:
Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.
Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”
Japan’s RIKEN research center has found misconduct in work that led to two controversial Nature papers, purporting to show an easy way to create stem cells, that have been dogged by criticism for months.
Here’s an excerpt from today’s statement about “six items [RIKEN] has been investigating:”
There have been a number of developments in the unraveling of two Nature studies out of the RIKEN Institute in Japan and Harvard purporting to show an easy way to create stem cells. There was an interim report of RIKEN’s investigation last Friday, and more details emerged this week.
And today, the Japan Times reported that last week, a correction of a 2011 paper by many of the same authors appeared in Tissue Engineering Part A. Here’s the correction notice, dated March 13: Read the rest of this entry »
Five of them appear in Molecular and Cellular Biology: Read the rest of this entry »